<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:series="https://publishpress.com/"
	>

<channel>
	<title>Overdose Tags - Differential Diagnosis of</title>
	<atom:link href="https://ddxof.com/tag/overdose/feed/" rel="self" type="application/rss+xml" />
	<link>https://ddxof.com/tag/overdose/</link>
	<description>A systematic approach to the evaluation and management of various complaints.</description>
	<lastBuildDate>Fri, 24 Jan 2020 21:41:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://ddxof.com/wp-content/uploads/2017/08/cropped-ddxof@1x-1-32x32.png</url>
	<title>Overdose Tags - Differential Diagnosis of</title>
	<link>https://ddxof.com/tag/overdose/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">46076767</site>	<item>
		<title>Toxicology</title>
		<link>https://ddxof.com/toxicology/</link>
					<comments>https://ddxof.com/toxicology/#comments</comments>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Sat, 29 Oct 2016 17:17:56 +0000</pubDate>
				<category><![CDATA[Toxicology]]></category>
		<category><![CDATA[Overdose]]></category>
		<guid isPermaLink="false">http://ddxof.com/?p=1873</guid>

					<description><![CDATA[<p>Toxic Alcohols Overview Toxic metabolites produced by alcohol dehydrogenase which can be inhibited by ethanol or fomepizole Fomepizole: 15mg/kg loading dose, 10mg/kg q12h x4 doses then 15mg/kg q12h (stimulates own metabolism); if dialysis, q4h Diagnosis: osmolar gap (&#62;14), 2Na + Glu/18 + BUN/2.8 + EtOH/4.6 Treatment ADH inhibition HCO3 Hemodialysis Supportive care Hypoglycemia: dextrose Methanol... <a class="more-link" href="https://ddxof.com/toxicology/">Continue reading <span class="meta-nav">&#8594;</span></a></p>
<p>The post <a href="https://ddxof.com/toxicology/">Toxicology</a> appeared first on <a href="https://ddxof.com">Differential Diagnosis of</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="row-fluid">
<div class="span8 offset">
<h2 id="drugs-of-abuse">Drugs of Abuse</h2>
<h3>Synthetic Cannabinoids (Spice, K2)</h3>
<ul>
<li>Symptoms: anxiety, paranoia, tachycardia</li>
<li>Unique symptoms compared to traditional cannabinoids: psychosis, seizure, diaphoresis</li>
</ul>
<h3>Hallucinogenic amphetamines (ecstasy, MDMA)</h3>
<ul>
<li>Increased serotonergic activity</li>
<li>Management: supportive care (IVF, cooling for hyperthermia), benzodiazepines</li>
</ul>
<h3>Gamma-hydroxybutyrate (GHB)</h3>
<ul>
<li>Symptoms: euphoria, hypersexuality, rapid onset/clearance</li>
<li>Signs: bradycardia, bradypnea, coma with rapid awakening</li>
<li>Management: intubation for depressed GCS</li>
<li>Withdrawal: symptoms and treatment identical to ethanol withdrawal, consider baclofen</li>
</ul>
<h3>Cathinone (bath salts)</h3>
<ul>
<li>Symptoms: hallucinations</li>
<li>Signs: tachycardia, hypertension, tremor, mydriasis, diaphoresis, hyperthermia, bruxism</li>
<li>Management: benzodiazepines, consider paralysis, avoid beta-blockers</li>
</ul>
<h3>Cocaine</h3>
<ul>
<li>MOA: increase catecholamines, Na-channel blockade</li>
<li>Toxicity: HTN, tachycardia, hyperthermia, rhabdomyolysis, MI, seizure, VT</li>
<li>Management: benzodiazepines, cooling, anti-hypertensives (nitrate, CCB, not B-blocker)</li>
</ul>
<h3>Amphetamine</h3>
<ul>
<li>Toxicity: HTN, tachycardia, hyperthermia, rhabdomyolysis, intracranial hemorrhage</li>
<li>Management: same as cocaine</li>
</ul>
<h3>Benzodiazepines</h3>
<ul>
<li>Toxicity: sedation, respiratory depression</li>
<li>Management: consider flumazenil 0.2mg IV q1min x1-5</li>
</ul>
</div>
<div class="span4 offset">
<div class="toggle-group">
<div class="toggle">
<h4 class="active">Table of contents</h4>
<div class="toggle-content">
<ol>
<li><a href="#drugs-of-abuse">Drugs of Abuse</a></li>
<li><a href="#toxic-alcohols">Toxic Alcohols</a></li>
<li><a href="#analgesics">Analgesics</a></li>
<li><a href="#anesthetics">Anesthetics</a></li>
<li><a href="#anti-cholinergics">Anti-cholinergics</a></li>
<li><a href="#anti-emetics">Anti-emetics</a></li>
<li><a href="#anti-hypertensives">Anti-hypertensives</a></li>
<li><a href="#anti-hyperglycemics">Anti-hyperglycemics</a></li>
<li><a href="#environmental">Environmental</a></li>
<li><a href="#heavy-metals">Heavy Metals</a></li>
<li><a href="#other-drugs">Other Drugs</a></li>
<li><a href="#envenomations">Envenomations</a></li>
</ol>
</div>
</div>
</div>
</div>
</div>
<hr>
<h2 id="toxic-alcohols">Toxic Alcohols</h2>
<ul>
<li>Overview
<ul>
<li>Toxic metabolites produced by alcohol dehydrogenase which can be inhibited by ethanol or fomepizole</li>
<li>Fomepizole: 15mg/kg loading dose, 10mg/kg q12h x4 doses then 15mg/kg q12h (stimulates own metabolism); if dialysis, q4h</li>
</ul>
</li>
<li>Diagnosis: osmolar gap (&gt;14), 2Na + Glu/18 + BUN/2.8 + EtOH/4.6</li>
<li>Treatment
<ul>
<li>ADH inhibition</li>
<li>HCO<sub>3</sub></li>
<li>Hemodialysis</li>
<li>Supportive care</li>
<li>Hypoglycemia: dextrose</li>
</ul>
</li>
</ul>
<h3>Methanol</h3>
<ul>
<li>Component of antifreeze, windshield washer fluid</li>
<li>Metabolite formic acid which causes acidosis and blindness</li>
<li>Can give folate</li>
</ul>
<h3>Ethylene glycol</h3>
<ul>
<li>Component of antifreeze, automobile coolants, de-icing agents</li>
<li>Metabolite oxalic acid which precipitates calcium oxalate crystals and causes acute renal failure</li>
<li>Can give thiamine (100mg q6h), pyridoxine (500mg q6h), Mg</li>
</ul>
<h3>Isopropanol</h3>
<ul>
<li>Component of rubbing alcohol</li>
<li>Metabolite acetone which does not cause acidosis</li>
</ul>
<hr>
<h2 id="analgesics">Analgesics</h2>
<h3>Acetaminophen</h3>
<ul>
<li>Metabolism: glucoronidation, CYP450
<ul>
<li>CYP450 pathway produces toxic metabolite when glucoronidation overwhelmed</li>
<li>In pediatrics, sulfation process protective</li>
</ul>
</li>
<li>Toxic dose: &gt;150mg/kg, &gt;3g/day</li>
<li>Injury: liver (centrilobular necrosis), renal, pancreatic</li>
<li>Increased risk: induced CYP450 (chronic EtOH, rifampin, anti-epileptics)</li>
<li>Nomogram: applicable to single ingestion at 4-hours</li>
<li>Labs: PT/INR, LFT, lipase, chemistry</li>
<li>Management: NAC
<ul>
<li>PO: 140mg/kg, 70mg/kg q4h</li>
<li>IV: 150mg/kg, 50mg/kg over 4h, 100mg/kg over 16h</li>
</ul>
</li>
</ul>
<h3>NSAID</h3>
<ul>
<li>Symptoms
<ul>
<li>Acute: GI upset, low risk UGIB</li>
<li>Acute massive: acidosis, coma, seizures</li>
<li>Chronic: UGIB, nephropathy, agranulocytosis</li>
</ul>
</li>
</ul>
<h3>Aspirin</h3>
<ul>
<li>Signs: tachycardia, hyperthermia, tachypnea/hyperpnea</li>
<li>Severe: cerebral and pulmonary edema, CNS hypoglycemia</li>
<li>Labs: primary respiratory alkalosis with metabolic acidosis</li>
<li>Management
<ul>
<li>Hypoglycemia (CNS) treatment</li>
<li>Bicarbonate infusion (urine pH &gt; 8)</li>
<li>Hemodialysis for pulmonary edema, cerebral edema, renal failure, acidemia, level &gt;100mg/dL (acute) or &gt; 60mg/dL (chronic)</li>
</ul>
</li>
</ul>
<h3>Opioids</h3>
<ul>
<li>Symptoms: respiratory depression, miosis</li>
<li>Management: naloxone 0.04mg, 0.4mg, 2mg</li>
<li>Withdrawal: nausea/vomiting, diarrhea, abdominal pain, piloerection
<ul>
<li>Neonates: seizure, death</li>
</ul>
</li>
<li>Complications with specific agents:
<ul>
<li>Meperidine, tramadol: seizures</li>
<li>Methadone: QT prolongation</li>
</ul>
</li>
</ul>
<hr>
<h2 id="anesthetics">Anesthetics</h2>
<h3>Lidocaine</h3>
<ul>
<li>Mechanism: Na-channel blockade</li>
<li>Types:
<ul>
<li>Ester (one “i”): cocaine, procaine, benzocaine</li>
<li>Amide (two “i&#8221;): lidocaine, bupivacaine</li>
</ul>
</li>
<li>Toxicity
<ul>
<li>Dose: 4mg/kg, 7mg/kg with epinephrine</li>
<li>CNS: perioral numbness, slurred speech, seizure</li>
<li>CV: VT, VF, AV block</li>
<li>Methemoglobinemia: methylene blue</li>
</ul>
</li>
<li>Treatment
<ul>
<li>Seizure management</li>
<li>Bicarbonate for dysrhythmia</li>
<li>Intralipid</li>
</ul>
</li>
</ul>
<hr>
<div class="row-fluid">
<div class="span8 offset">
<h2 id="anti-cholinergics">Anti-cholinergics</h2>
<table>
<thead>
<tr>
<th>Sympathetic</th>
<th>Parasympathetic</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mydriasis</td>
<td>Miosis</td>
</tr>
<tr>
<td>Bronchodilation</td>
<td>Bronchospasm/bronchorrhea</td>
</tr>
<tr>
<td>Tachycardia</td>
<td>Bradycardia</td>
</tr>
<tr>
<td>Urinary retention</td>
<td>Urinary incontinence</td>
</tr>
<tr>
<td>Hyperglycemia</td>
<td>Salivation/lacrimation</td>
</tr>
<tr>
<td>Diaphoresis</td>
<td>Increased GI motility</td>
</tr>
</tbody>
</table>
<ul>
<li>Examples
<ul>
<li>Atropine</li>
<li>Anti-histamine</li>
<li>TCA</li>
<li>Phenothiazines</li>
<li>Jimson weed</li>
</ul>
</li>
<li>Symptoms
<ul>
<li>Peripheral: mydriasis, anhidrosis, flushing, hyperthermia, ileus, dry mucous membranes, AUR</li>
<li>Central: agitation (passive), delirium, coma, seizure</li>
</ul>
</li>
<li>Treatment
<ul>
<li>Supportive</li>
<li>Benzodiazepines</li>
<li>Theoretically physostigmine
<ul>
<li>Avoid in seizure, QRS-widening, reactive airway disease</li>
<li>Possible diagnostic use</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div class="span4 offset">
<div class="toggle-group"></div>
<div class="toggle">
<h4 class="active">Drugs causing miosis (COPS)</h4>
<div class="toggle-content">
<ul>
<li>C: cholinergics</li>
<li>O: opioids</li>
<li>P: phenothiazines</li>
<li>S: sedatives</li>
</ul>
</div>
</div>
<div class="toggle">
<h4 class="">Drugs causing QT-prolongation</h4>
<div class="toggle-content">
<ul>
<li>Examples:
<ul>
<li>Phenothiazines</li>
<li>Anti-arrhythmics</li>
<li>Butyrophenones (ex. haloperidol)</li>
<li>Macrolides</li>
<li>Fluoroquinolones</li>
<li>Methadone</li>
<li>Ondansetron</li>
<li>Atypical antipsychotics</li>
</ul>
</li>
<li>Treatment
<ul>
<li>Magnesium sulfate 2g IV over 1min</li>
<li>Overdrive pacing (transcutaneous, transvenous if not captured)</li>
<li>Consider isoproterenol (pharmacologic overdrive)</li>
</ul>
</li>
</ul>
</div>
</div>
<div class="toggle">
<h4 class="">Serotonin syndrome</h4>
<div class="toggle-content">
<ul>
<li>Cause: exposure to serotonergic agent(s)</li>
<li>Symptoms: agitation, mydriasis, tremor/clonus in lower extremities, tachycardia, hyperthermia</li>
<li>Management
<ul>
<li>Supportive care (IVF, vasopressors)</li>
<li>Cooling measures and paralysis for hyperthermia</li>
<li>Benzodiazepines</li>
<li>Cyproheptadine 12mg PO/NG</li>
<li>Dexmedetomidine infusion</li>
</ul>
</li>
</ul>
</div>
</div>
</div>
</div>
<hr>
<h2 id="anti-emetics">Anti-emetics</h2>
<h3>Phenothiazines</h3>
<ul>
<li>Examples: compazine (prochlorperazine), phenergan (promethazine)</li>
<li>MOA: DA-antagonist</li>
<li>AE: sedation, dystonia, parkinsonism</li>
<li>Toxicity: seizure, VT, hypotension (TCA-like)</li>
</ul>
<h3>5-HT3 antagonists</h3>
<ul>
<li>Examples: zofran (ondansetron), granisetron</li>
<li>Toxicity: QT-prolongation</li>
</ul>
<hr>
<h2 id="anti-hypertensives">Anti-hypertensives</h2>
<div class="row-fluid">
<div class="span8 offset">
<h3>Calcium channel blockers</h3>
<ul>
<li>Toxicity: hypotension, bradycardia, AV blockade, hyperglycemia</li>
<li>Management
<ul>
<li>Atropine: 0.5mg IV q2-3min</li>
<li>Glucagon: 5mg IV q10min x2 (with anti-emetic)</li>
<li>IVF, vasopressors (norepinephrine, epinephrine)</li>
<li>Calcium: 3g gluconate, 1-3g chloride</li>
<li>High-dose insulin: 1 unit/kg, monitor hypoglycemia/hypokalemia</li>
<li>Intralipid: 1.5mL/kg bolus then 0.25mL/kg/minute</li>
<li>GI decontamination</li>
<li>Pacing, IABP, ECMO</li>
</ul>
</li>
</ul>
<h3>Beta blockers</h3>
<ul>
<li>Toxicity: similar to CCB, hypoglycemia</li>
<li>Management: similar to CCB, calcium ineffective</li>
</ul>
<h3>Digoxin (foxglove, oleander)</h3>
<ul>
<li>MOA: inhibits Na/K ATPase, increases intracellular calcium (inotropic)</li>
<li>Toxicity
<ul>
<li>CV: bradycardia, hypotension</li>
<li>ECG: bidirectional VT, PVC, scooped ST-segment</li>
<li>CNS: agitation, psychosis</li>
<li>Visual: yellow-green vision, halo</li>
<li>Metabolic: hyperkalemia (acute), hypokalemia, hypomagnesemia</li>
</ul>
</li>
<li>Treatment
<ul>
<li>GI decontamination</li>
<li>Atropine</li>
<li>Transcutaneous pacing (avoid transvenous, irritable myocardium)</li>
<li>Digibind</li>
<li>Avoid calcium</li>
</ul>
</li>
</ul>
<h3>Clonidine</h3>
<ul>
<li>Toxicity: bradycardia, hypotension, opioid mimic (miosis, lethargy, respiratory depression)</li>
<li>Management: supportive care, stimulation for respiratory depression, atropine</li>
</ul>
</div>
<div class="span4 offset">
<div class="toggle-group">
<div class="toggle">
<h4 class="active">Sodium-channel blockers</h4>
<div class="toggle-content">
<ul>
<li>Drugs
<ul>
<li>TCA</li>
<li>Diphenhydramine</li>
<li>Procainamide</li>
<li>Carbamazepine</li>
</ul>
</li>
<li>ECG
<ul>
<li>QRS prolongation</li>
<li>Prominent “R” in aVR</li>
<li>RAD</li>
</ul>
</li>
<li>Treatment
<ul>
<li>Sodium bicarbonate</li>
</ul>
</li>
</ul>
</div>
</div>
</div>
</div>
</div>
<hr>
<div class="row-fluid">
<div class="span8 offset">
<h2 id="anti-hyperglycemics">Anti-hyperglycemics</h2>
<h3>Sulfonylurea</h3>
<ul>
<li>Symptoms: recurrent severe hypoglycemia</li>
<li><a href="https://ddxof.com/hypoglycemia/">Management</a>: octreotide 50-75mcg SQ/IM q6h</li>
</ul>
</div>
<div class="span4 offset">
<div class="toggle-group">
<div class="toggle">
<h4 class="active">Other agents that cause hypoglycemia</h4>
<div class="toggle-content">
<ul>
<li>EtOH</li>
<li>B-blocker</li>
<li>Quinine</li>
<li>Salicylate</li>
</ul>
</div>
</div>
</div>
</div>
</div>
<hr>
<h2 id="environmental">Environmental</h2>
<h3>Carbon monoxide</h3>
<ul>
<li>Source: combustion (gas heater, indoor barbeque)</li>
<li>Toxicity
<ul>
<li>General: influenza-like, multiple proximate affected individuals</li>
<li>GI: abdominal pain, nausea</li>
<li>CNS: headache, dizziness, confusion, ataxia, seizure</li>
<li>CV: palpitations, arrhythmia, hypotension, MI</li>
</ul>
</li>
<li>Treatment
<ul>
<li>T½: RA 6h, NRB 1h, 3atm 0.5h</li>
<li>Hyperbaric: neuro deficit, syncope, pregnancy, CV toxicity</li>
</ul>
</li>
</ul>
<h3>Cyanide</h3>
<ul>
<li>Mechanism: inhibits oxidative phosphorylation</li>
<li>Source: structural fire (wool, silk)</li>
<li>Symptoms: syncope, seizure, coma, cardiovascular collapse</li>
<li>Detection: severe lactic acidosis, “arterialization” of venous blood, “bitter almond” odor</li>
<li>Treatment
<ul>
<li>Hydroxycobalamin (Cyanokit): 5g IV, may repeat x1</li>
<li>Sodium thiosulfate 12.5g IV</li>
</ul>
</li>
</ul>
<h3>Methemoglobinemia</h3>
<ul>
<li>Mechanism: Fe<sup>2+</sup> converted to Fe<sup>3+</sup>, “functional anemia”</li>
<li>Source: nitrite (food), topical/local anesthetics, pyridium, dapsone, reglan</li>
<li>Detection: normal PaO2, SpO2 85% unresponsive to supplemental oxygen, ABG with co-oximetry</li>
<li>Management: methylene blue 1-2mg/kg IV if symptomatic or MetHb &gt;25%
<ul>
<li>Contraindicated in G6PD deficiency, treat with exchange transfusion or HBO</li>
</ul>
</li>
</ul>
<h3>Hydrogen Sulfide</h3>
<ul>
<li>Source: industrial, sulfur spring, sewer</li>
<li>Detection: “rotten egg” odor</li>
<li>Management: remove from source, supportive care</li>
</ul>
<h3>Hydrocarbon</h3>
<ul>
<li>Source: huffing canisters</li>
<li>Toxicity: VT/VF from myocardial sensitization</li>
<li>Management: beta-blockade</li>
<li>Complications: harmless if ingested, aspiration leads to ARDS</li>
</ul>
<h3>Hydrofluoric acid</h3>
<ul>
<li>Source: rust remover, wheel cleaner, glass etching</li>
<li>Symptoms: pain-out-of-proportion, delayed onset</li>
<li>Toxicity: Hypocalcemia (QTc prolongation, VT/VF/TdP), hyperkalemia, hypomagnesemia</li>
<li>Management: analgesia, topical calcium gluconate gel, intravenous calcium for large BSA involvement</li>
</ul>
<h3>Alkaline ingestion</h3>
<ul>
<li>Symptoms: esophageal perforation, delayed stricture</li>
</ul>
<h3>Acid ingestion</h3>
<ul>
<li>Symptoms: gastric perforation (rare), delayed gastric outlet obstruction</li>
<li>Findings: metabolic acidosis</li>
</ul>
<h3>Botulism</h3>
<ul>
<li>Sources
<ul>
<li>Adult: ingested preformed toxin</li>
<li>Infants: ingested spores (achlorhydric), in vivo toxin production</li>
<li>Wound: black tar heroin</li>
</ul>
</li>
<li>Symptoms: dysphagia, ptosis, diplopia, respiratory failure, descending paralysis
<ul>
<li>Infants: constipation, floppy</li>
</ul>
</li>
<li>Management: supportive care, intubation
<ul>
<li>Adults: Anti-toxin from CDC or local Department of Health</li>
<li>Infants: 100mg/kg IV x 1 dose (BabyBIG)</li>
</ul>
</li>
</ul>
<hr>
<h2 id="heavy-metals">Heavy Metals</h2>
<h3>Iron</h3>
<ul>
<li>Dose
<ul>
<li>Ferrous sulfate: 20% elemental iron</li>
<li>Toxic: &gt;20mg/kg</li>
<li>Lethal: &gt;60mg/kg (1 tablet 325mg ferrous sulfate per kilogram)</li>
</ul>
</li>
<li>Toxicity: corrosive, anti-coagulant, hepatotoxic</li>
<li>Course
<ul>
<li>Stage I: GI effects, emesis with hematemesis</li>
<li>Stage II: Quiescent</li>
<li>Stage III: Systemic, multi-organ system dysfunction</li>
<li>Stage IV: Resolution, gastric scarring and outlet obstruction</li>
</ul>
</li>
<li>Workup
<ul>
<li>CBC/BMP</li>
<li>LFT</li>
<li>Lactate</li>
<li>Fe level</li>
<li>KUB (if positive consider WBI)</li>
</ul>
</li>
<li>Treatment
<ul>
<li>Decontamination: no activated charcoal, consider WBI</li>
<li>Deferoxamine: 15mg/kg/hr</li>
</ul>
</li>
</ul>
<h3>Lead</h3>
<ul>
<li>Source: paint, batteries</li>
<li>Toxicity
<ul>
<li>Acute: headache, encephalopathy, seizure</li>
<li>Chronic: malaise, weight loss, arthralgia, anemia (basophilic stippling)</li>
</ul>
</li>
<li>Diagnosis: lead level, wrist drop</li>
<li>Management: chelation (BAL, EDTA, DMSA) for level &gt;50ug/dL or asymptomatic &gt;70ug/dL</li>
</ul>
<h3>Lithium</h3>
<ul>
<li>Source: iatrogenic, drug-drug interaction</li>
<li>Symptoms
<ul>
<li>GI: nausea/vomiting, diarrhea</li>
<li>CNS: tremor, coma</li>
<li>CV: TWI, QT-prolongation</li>
</ul>
</li>
<li>Management
<ul>
<li>IVF, encourage renal elimination</li>
<li>Hemodialysis</li>
</ul>
</li>
</ul>
<hr>
<h2 id="other-drugs">Other Drugs</h2>
<h3>Disulfuram</h3>
<ul>
<li>MOA: aldehyde dehydrogenase inhibitor</li>
<li>Symptoms: increased acetaldehyde leads to flushing, headache, nausea/vomiting, tachycardia, hypotension</li>
<li>Management: antihistamine, IVF, vasopressors</li>
<li>Other agents causing disulfuram-like reaction: metronidazole, INH, sulfonylurea</li>
</ul>
<h3>Isoniazid</h3>
<ul>
<li>Toxicity: seizure</li>
<li>Management: pyridoxine 5g IV, repeat x1</li>
</ul>
<h3>Theophyline</h3>
<ul>
<li>Toxicity: seizure</li>
<li>Management
<ul>
<li>Decontamination: AC</li>
<li>Seizures: benzodiazepines</li>
<li>Tachyarrhythmia (commonly MAT): beta-blockade</li>
<li>Hemodialysis: acute &gt; 100mg/L, chronic &gt;30mg/L</li>
</ul>
</li>
</ul>
<h3>Monoamine oxidase inhibitors</h3>
<ul>
<li>Toxicity: food/drug interaction</li>
<li>Symptoms: tachycardia, hypertension, hyperthermia, agitation</li>
<li>Management: cooling, IVF, management of hyper/hypotension</li>
</ul>
<h3>Phenytoin</h3>
<ul>
<li>Oral: cerebellar dysfunction (ataxia), CNS depression</li>
<li>IV: hypotension (suspension contains propylene glycol)</li>
</ul>
<h3>Nutritional Supplements</h3>
<ul>
<li>Fat-soluble vitamins
<ul>
<li>A: benign intracranial hypertension</li>
<li>D: hypercalcemia</li>
</ul>
</li>
</ul>
<hr>
<h2 id="envenomations">Envenomations</h2>
<h3>Snake</h3>
<ul>
<li>Crotalid (rattle), elapidae (coral)</li>
<li>Symptoms
<ul>
<li>Local reaction: edema, hemorrhagic bullae</li>
<li>Systemic: perioral numbness, fasciculations</li>
<li>Severe: thrombocytopenia, decreased fibrinogen</li>
</ul>
</li>
<li>Management: Crofab 5 vials</li>
</ul>
<h3>Spider</h3>
<ul>
<li>Black widow
<ul>
<li>Identification: hourglass on abdomen</li>
<li>Symptoms: painful bite, target-appearance, rarely “acute abdomen”</li>
<li>Management: analgesia, anti-venom, tetanus</li>
</ul>
</li>
<li>Brown recluse
<ul>
<li>Identification: violin shape on head</li>
<li>Geography: Southeast, Midwest</li>
<li>Symptoms: painless bite, local reaction, delayed healing with eschar</li>
<li>Rare: hemolysis, DIC, shock</li>
<li>Management: supportive care, antibiotics if superinfected, consider dapsone, tetanus</li>
</ul>
</li>
</ul>
<h3>Scorpion (Centruroides)</h3>
<ul>
<li>Geography: Arizona</li>
<li>Symptoms
<ul>
<li>Autonomic: HTN, tachycardia, diaphoresis</li>
<li>CNS: opsoclonus, slurred speech, dysphagia</li>
</ul>
</li>
<li>Management: anti-venom, supportive care, analgesia, tetanus</li>
</ul>
<h3>Marine</h3>
<ul>
<li>Ciguatera
<ul>
<li>Source: toxin bioconcentrated in fish</li>
<li>Symptoms: gastroenteritis, hot/cold-reversal, “loose teeth” sensation</li>
<li>Management: mannitol</li>
</ul>
</li>
<li>Scombroid
<ul>
<li>Source: poorly-refrigerated fish, histamine-like</li>
<li>Symptoms: flushing trunk/face (distinguish from allergic reaction), gastroenteritis</li>
<li>Management: supportive care, IVF, anti-histamine, bronchodilators if indicated</li>
</ul>
</li>
<li>Paralytic shellfish poisoning
<ul>
<li>Source: bivalve</li>
<li>Symptoms: gastroenteritis, paralysis</li>
<li>Management: supportive, intubation</li>
</ul>
</li>
<li>Jellyfish and Cnidaria
<ul>
<li>Source: nematocyst</li>
<li>Symptoms: burning pain, pruritus</li>
<li>Severe: Irakundji syndrome (HTN, pulmonary edema)</li>
<li>Management: supportive, analgesia, box jellyfish antidote, consider vinegar</li>
</ul>
</li>
<li>Stingray
<ul>
<li>Source: heat-labile toxin</li>
<li>Management: affected area in warm water, tetanus, ciprofloxacin (Vibrio)</li>
</ul>
</li>
</ul>
<h3>Mushrooms</h3>
<ul>
<li>Amanita: centrilobular necrosis, similar to acetaminophen</li>
<li>Gyronatum: similar to INH (seizure and treatment), may cause methemoglobinemia</li>
<li>Symptoms: muscarinic (SLUDGE)
<ul>
<li>Early onset generally benign, delayed onset (&gt;6h) suggests more serious course</li>
</ul>
</li>
<li>Management: atropine, glycopyrrolate, IVF</li>
</ul>
<h3>Pesticides</h3>
<ul>
<li>Organophosphate: irreversible</li>
<li>Carbamate: reversible</li>
<li>Symptoms: muscarinic (SLUDGE)</li>
<li>Treatment: atropine 2-6mg IV double q5min to control secretions, pralidoxime (for organophosphates)</li>
</ul>
<h3>Strychnine</h3>
<ul>
<li>Source: rodenticide</li>
<li>Symptoms: myoclonus, opisthotonus, agitation</li>
<li>Management: benzodiazepines, airway protection, paralysis</li>
</ul>
<p>The post <a href="https://ddxof.com/toxicology/">Toxicology</a> appeared first on <a href="https://ddxof.com">Differential Diagnosis of</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://ddxof.com/toxicology/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		
		<series:name><![CDATA[SimWars]]></series:name>
<post-id xmlns="com-wordpress:feed-additions:1">1873</post-id>	</item>
		<item>
		<title>Atypical Antipsychotic Overdose</title>
		<link>https://ddxof.com/atypical-antipsychotic-overdose/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Tue, 23 Feb 2016 21:06:11 +0000</pubDate>
				<category><![CDATA[Psychiatry]]></category>
		<category><![CDATA[Toxicology]]></category>
		<category><![CDATA[Overdose]]></category>
		<guid isPermaLink="false">http://ddxof.com/?p=1495</guid>

					<description><![CDATA[<p>History &#038; Physical 38M, unknown medical history, brought in after being found unresponsive next to an empty bottle of Seroquel. Presenting vital signs notable for blood pressure of 96/43, heart rate 103. Examination reveals tentatively protected airway (GCS E2 M5 V3, SpO2 100%, RR 14), normal pupil diameter and reactivity, dry mucous membranes with thick... <a class="more-link" href="https://ddxof.com/atypical-antipsychotic-overdose/">Continue reading <span class="meta-nav">&#8594;</span></a></p>
<p>The post <a href="https://ddxof.com/atypical-antipsychotic-overdose/">Atypical Antipsychotic Overdose</a> appeared first on <a href="https://ddxof.com">Differential Diagnosis of</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h2>History &#038; Physical</h2>
<p>38M, unknown medical history, brought in after being found unresponsive next to an empty bottle of Seroquel. Presenting vital signs notable for blood pressure of 96/43, heart rate 103. Examination reveals tentatively protected airway (GCS E2 M5 V3, SpO2 100%, RR 14), normal pupil diameter and reactivity, dry mucous membranes with thick vomitus in oral cavity.</p>
<p>Laboratory evaluation was unremarkable, and there was no evidence of aspiration on chest radiography. ECG showed sinus tachycardia without QT prolongation. Blood pressure increased to normal range with fluid resuscitation. The patient’s mental status progressively improved and he was discharged after six hours of uneventful continuous cardiac monitoring. </p>
<h2>Toxidrome Summary<sup>1</sup></h2>
<table>
<thead>
<tr>
<th>Class</th>
<th>Vital Signs</th>
<th>Mental Status</th>
<th>Pupils</th>
<th>Skin</th>
<th>Other</th>
<th>Examples</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anti-cholinergic</td>
<td><i class="fa fa-caret-up " ></i> T<br /> <i class="fa fa-caret-up " ></i> HR<br /> <i class="fa fa-caret-up " ></i> BP</td>
<td>Delirium<br /> Agitation<br /> Coma</td>
<td>Mydriasis</td>
<td>Dry</td>
<td>Urinary retention<br /> <i class="fa fa-caret-down " ></i> BS</td>
<td>Anti-histamines<br /> Anti-parkinson<br /> Anti-psychotic<br /> Anti-depressant</td>
</tr>
<tr>
<td>Sympathomimetic</td>
<td><i class="fa fa-caret-up " ></i> T<br /> <i class="fa fa-caret-up " ></i> HR<br /> <i class="fa fa-caret-up " ></i> BP</td>
<td>Agitation<br /> Hallucination<br /> Paranoia</td>
<td>Mydriasis</td>
<td>Diaphoresis</td>
<td>Tremor<br /> Hyperreflexia</td>
<td>Cocaine<br /> Amphetamine<br /> Ephedrine</td>
</tr>
<tr>
<td>Opioid/Sedative</td>
<td><i class="fa fa-caret-down " ></i> HR<br /> <i class="fa fa-caret-down " ></i> RR<br /> <i class="fa fa-caret-down " ></i> BP</td>
<td>CNS depression<br /> Coma</td>
<td>Miosis</td>
<td>&nbsp;</td>
<td>Hyporeflexia<br /> Needle marks</td>
<td>Opioids<br /> Benzo<br /> Barbiturates</td>
</tr>
</tbody>
</table>
<h2>Evaluation<sup>1,2</sup></h2>
<ul>
<li>POC Glucose</li>
<li>ECG (QT interval)</li>
<li>Serum acetaminophen, salicylate, EtOH level</li>
<li>Serum drug levels if known (anti-epileptics)</li>
<li>Urine toxicology screen</li>
<li>Chemistry (metabolic acidosis, electrolytes, renal function)</li>
<li>LFT (hepatotoxicity)</li>
<li>CK (rhabdomyolysis)</li>
<li>Serum osmolarity (osmolar gap)</li>
<li>UA with microscopy (crystals in ethylene glycol poisoning)</li>
<li>ABG  (carboxyhemoglobin, methemoglobin)</li>
</ul>
<h2>Pharmacology, Toxicity and Management of Second Generation Antipsychotic (SGA) Overdose<sup>3</sup></h2>
<p><a href="https://www.lucidchart.com/publicSegments/view/55bc68ca-3de4-4bf7-b909-12ba0a008c51/image.png"><img fetchpriority="high" decoding="async" src="https://www.lucidchart.com/publicSegments/view/55bc68ca-3de4-4bf7-b909-12ba0a008c51/image.png" width="975" height="1056" alt="Pharmacology, Toxicity and Management of Second Generation Antipsychotic (SGA) Overdose" class="alignnone" /></a></p>
<h2>References</h2>
<ol>
<li>Kulig, K. (2013). General Approach to the Poisoned Patient. In Rosen&#8217;s Emergency Medicine &#8211; Concepts and Clinical Practice (8th ed., Vol. 1, pp. 1954-1959). Elsevier Health Sciences.</li>
<li>Wittler, M., &#038; Lavonas, E. (2013). Antipsychotics. In Rosen&#8217;s Emergency Medicine &#8211; Concepts and Clinical Practice (8th ed., Vol. 1, pp. 2047-2051). Elsevier Health Sciences.</li>
<li>Levine M, Ruha A-M. Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management. CNS Drugs. 2012;26(7):601–611.</li>
<li><a href="https://www.wikem.org/wiki/Antipsychotic_toxicity">WikEM: Antipsychotic toxicity</a></li>
</ol>
<p>The post <a href="https://ddxof.com/atypical-antipsychotic-overdose/">Atypical Antipsychotic Overdose</a> appeared first on <a href="https://ddxof.com">Differential Diagnosis of</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">1495</post-id>	</item>
	</channel>
</rss>
